SCHEMBL4198230

SCHEMBL4198230

O=C(Nc1ccc(Cl)cc1Cl)c1cc[nH]n1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.63
CYP1A2 P05177 1/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2C9 P11712 1/20 0.63
CYP2C19 P33261 1/20 0.63
NPC1 O15118 6/20 0.50
RAB9A P51151 6/20 0.50
KDM4E B2RXH2 2/20 0.50
RXFP1 Q9HBX9 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 2/20 0.50
USP2 O75604 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
POLB P06746 4/20 0.49
ATM Q13315 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
TSHR P16473 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4195751 0.88 MEN1 (0.53) ALOX15CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4186735 0.85 ALOX15 (0.65) ALOX15CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4199011 0.85 NPC1 (0.53) ALOX15CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4205361 0.85 RAB9A (0.56) ALOX15CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4188965 0.84 MEN1 (0.45) ALOX15CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4198299 0.84 KCNMA1 (0.59) NPC1RAB9AKDM4EHPGDPOLB
SCHEMBL4198306 0.82 ALOX15 (0.44) ALOX15CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4196298 0.79 ALDH1A1 (0.46) ALOX15CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4253110 0.79 ALOX15 (0.68) ALOX15CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4748938 0.78 CYP1A2 (0.58) ALOX15CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088463-A1 Pyrazoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088463-A1 Pyrazoles Useful in the Treatment of Inflammation ALOX15, ALOX5, ALOX15B ALOX15 1/4885CYP1A2 32/4885CYP3A4 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.